Arch Venture Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Hold |
2,008,809
| – | – | 7.54% | 5 |
|
|
2025
Q1 | $9.12M | Hold |
2,008,809
| – | – | 4.42% | 5 |
|
|
2024
Q4 | $11.3M | Hold |
2,008,809
| – | – | 4.92% | 4 |
|
|
2024
Q3 | $9.72M | Hold |
2,008,809
| – | – | 3.73% | 5 |
|
|
2024
Q2 | $9.8M | Hold |
2,008,809
| – | – | 3.69% | 4 |
|
|
2024
Q1 | $26.7M | Hold |
2,008,809
| – | – | 33.23% | 1 |
|
|
2023
Q4 | $28M | Hold |
2,008,809
| – | – | 17.13% | 2 |
|
|
2023
Q3 | $26.6M | Hold |
2,008,809
| – | – | 17.3% | 2 |
|
|
2023
Q2 | $37.7M | Hold |
2,008,809
| – | – | 23.26% | 2 |
|
|
2023
Q1 | $29M | Hold |
2,008,809
| – | – | 13.98% | 4 |
|
|
2022
Q4 | $38.9M | Hold |
2,008,809
| – | – | 9.96% | 5 |
|
|
2022
Q3 | $69M | Sell |
2,008,809
-500,000
| -20% | -$17.2M | 8.95% | 5 |
|
|
2022
Q2 | $38.3M | Hold |
2,508,809
| – | – | 4.67% | 5 |
|
|
2022
Q1 | $57.3M | Hold |
2,508,809
| – | – | 8.18% | 4 |
|
|
2021
Q4 | $92.5M | Buy |
+2,508,809
| New | +$92.5M | 9.79% | 4 |
|